MicroRNA identification in plasma and serum: A new tool to diagnose and monitor diseases

Expert Opinion on Biological Therapy

Volumn 9, Issue 6, 2009, Pages 703-711

  Cortez, Maria Angelica ^a   Calin, George Adrian ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer; microRNA; Plasma; Serum

Indexed keywords

2' O METHOXYETHYLPHOSPHOROTHIOATE; ANTAGOMIR; ANTISENSE OLIGONUCLEOTIDE; BIOLOGICAL MARKER; MICRORNA; MICRORNA 101B; MICRORNA 122; MICRORNA 126; MICRORNA 141; MICRORNA 143; MICRORNA 145; MICRORNA 15A; MICRORNA 16A; MICRORNA 17; MICRORNA 17 3P; MICRORNA 17 92; MICRORNA 184; MICRORNA 18A; MICRORNA 192; MICRORNA 19A; MICRORNA 19B 1; MICRORNA 20A; MICRORNA 21; MICRORNA 223; MICRORNA 29A; MICRORNA 31; MICRORNA 92; MICRORNA 92 1; MICRORNA 93; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

BIOGENESIS; BLOOD LEVEL; CARCINOGENESIS; DIAGNOSTIC PROCEDURE; GENE THERAPY; GENETIC STABILITY; HUMAN; NONHUMAN; OLIGONUCLEOTIDE THERAPY; PROTEIN EXPRESSION; REVIEW; RNA STABILITY; SCREENING TEST;

BIOLOGICAL MARKERS; DISEASE; HUMANS; MICRORNAS; MONITORING, PHYSIOLOGIC;

EID: 67649120071     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712590902932889     Document Type: Review

References (93)

1. Ambros V. The functions of animal microRNAs. Nature 2004;431:350-355 • An important review on miRNA functions. (Pubitemid 39265675)
2. Zamore PD, Haley B. Ribo-genome: the big world of small RNAs. Science 2005;309:1519-1524
3. Meister G. miRNAs get an early start on translational silencing. Cell 2007;131:25-28 (Pubitemid 47498539)
4. Lewis BP, Shih IH, Jones-Rhoades MW, et al. Prediction of mammalian microRNA targets. Cell 2003;115:787-798 (Pubitemid 38058492)
5. Xie X, Mikkelsen TS, Gnirke A, et al. Systematic discovery of regulatory motifs in conserved regions of the human genome, including thousands of CTCF insulator sites. Proc Natl Acad Sci USA 2007;104:7145-7150 (Pubitemid 47186023)
6. Krek A, Grun D, Poy MN, et al. Combinatorial microRNA target predictions. Nat Genet 2005;37:495-500 (Pubitemid 40617277)
7. Lall S, Grun D, Krek A, et al. A genome-wide map of conserved microRNA targets in C. elegans. Curr Biol 2006;16:460-471 (Pubitemid 43343706)
8. Lee Y, Jeon K, Lee JT, et al. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 2002;21:4663-4670 (Pubitemid 34984353)
9. Zeng Y, Yi R, Cullen BR. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci USA 2003;100:9779-9784 (Pubitemid 37087018)
10. Lee Y, Ahn C, Han J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003;425:415-419 (Pubitemid 37187272)
11. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003;17:3011-3016 (Pubitemid 38040764)
12. Lund E, Guttinger S, Calado A, et al. Nuclear export of microRNA precursors. Science 2004;303:95-98 (Pubitemid 38055779)
13. Bohnsack MT, Czaplinski K, Gorlich D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 2004;10:185-191 (Pubitemid 38129823)
14. Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005;15:563-568 (Pubitemid 41262414)
15. Jannot G, Simard MJ. Tumour-related microRNA functions in Caenorhabditis elegans. Oncogene 2006;25:6197-6201 (Pubitemid 44527850)
16. Umbach JL, Kramer MF, Jurak I, et al. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 2008;454:780-783
17. Thum T, Catalucci D, Bauersachs J. MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc Res 2008;79:562-570
18. Calin GA, Liu CG, Sevignani C, et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 2004;101:11755-11760 (Pubitemid 39095368)
19. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002;99:15524-15529 • The first report of miRNA in cancer. (Pubitemid 35403967)
20. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005;102:13944-13949 (Pubitemid 41377683)
21. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-838 • The first report of bead-based miRNA profiling. (Pubitemid 40839735)
22. Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-198 (Pubitemid 43357945)
23. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6:857-866 (Pubitemid 44629897)
24. McManus MT. MicroRNAs and cancer. Semin Cancer Biol 2003;13:253-258
25. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005;122:6-7 (Pubitemid 40977933)
26. Chin LJ, Slack FJ. A truth serum for cancer - microRNAs have major potential as cancer biomarkers. Cell Res 2008;18:983-984
27. Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005;65:7065-7070 (Pubitemid 41161233)
28. Ciafre SA, Galardi S, Mangiola A, et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 2005;334:1351-1358 (Pubitemid 41074723)
29. Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006;25:2537-2545
30. He H, Jazdzewski K, Li W, et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 2005;102:19075-19080 (Pubitemid 43049568)
31. Michael MZ, O'Connor SM, van Holst Pellekaan NG, et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003;1:882-891 (Pubitemid 37288707)
32. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006;103:2257-2261 (Pubitemid 43271657)
33. Rosenfeld N, Aharonov R, Meiri E, et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 2008;26:462-469
34. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004;101:2999-3004 (Pubitemid 38327724)
35. Zhang L, Huang J, Yang N, et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 2006;103:9136-9141 (Pubitemid 43902545)
36. Garzon R, Croce CM. MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol 2008;15:352-358
37. Jongen-Lavrencic M, Sun SM, Dijkstra MK, et al. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 2008;111:5078-5085
38. Dixon-McIver A, East P, Mein CA, et al. Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS ONE 2008;3:e2141 (Pubitemid 352025167)
39. Varambally S, Cao Q, Mani RS, et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 2008;322:1695-1699
40. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259-269 • An interesting review about miRNA functions in human cancer.
41. He L, He X, Lowe SW, Hannon GJ. microRNAs join the p53 network - another piece in the tumour-suppression puzzle. Nat Rev Cancer 2007;7:819-822 (Pubitemid 350006254)
42. Bommer GT, Gerin I, Feng Y, et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007;17:1298-1307 (Pubitemid 47176893)
43. Chang TC, Wentzel EA, Kent OA, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007;26:745-752 (Pubitemid 46856245)
44. Johnson SM, Grosshans H, Shingara J, et al. RAS is regulated by the let-7 microRNA family. Cell 2005;120:635-647 (Pubitemid 40343076)
45. Meng F, Henson R, Wehbe-Janek H, et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007;133:647-658 (Pubitemid 47187346)
46. Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008;133:217-222
47. Ikeda S, Kong SW, Lu J, et al. Altered microRNA expression in human heart disease. Physiol Genomics 2007;31:367-373 (Pubitemid 350127777)
48. Pauley KM, Satoh M, Chan AL, et al. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 2008;10:R101
49. Sheedy FJ, O'neill LA. Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann Rheum Dis 2008;67(Suppl 3):iii50-5
50. Tang X, Tang G, Ozcan S. Role of microRNAs in diabetes. Biochim Biophys Acta 2008;1779:697-701
51. Chen JF, Callis TE, Wang DZ. microRNAs and muscle disorders. J Cell Sci 2009;122:13-20
52. Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008;141:672-675 • One of the first studies of miRNA detection in cancer patients' serum. (Pubitemid 351667616)
53. Meng F, Henson R, Wehbe-Janek H, et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007;133:647-658 (Pubitemid 47187346)
54. Asangani IA, Rasheed SA, Nikolova DA, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008;27:2128-2136
55. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105:10513-10518
56. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997-1006
57. Resnick KE, Alder H, Hagan JP, et al. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009;112:55-59
58. Feng G, Li G, Gentil-Perret A, et al. Elevated serum-circulating RNA in patients with conventional renal cell cancer. Anticancer Res 2008;28:321-326 (Pubitemid 351362920)
59. Wong TS, Liu XB, Wong BY, et al. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 2008;14:2588-2592
60. Skog J, Wurdinger T, van RS, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008;10:1470-1476
61. Ng EK, Chong WW, Jin H, et al. Differential expression of microRNAs in plasma of colorectal cancer patients: a potential marker for colorectal cancer screening. Gut 2009. [Epub 6 Feb 2009; doi: 10.1136/gut.2008.167817 ]
62. O'Donnell KA, Wentzel EA, Zeller KI, et al. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005;435:839-843 (Pubitemid 40839736)
63. Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 2009;106:4402-4407
64. Hunter MP, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 2008;3:e3694
65. Chim SS, Shing TK, Hung EC, et al. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 2008;54:482-490 • An interesting report of miRNA in pregnancy, and one of the first reports of placental miRNA detection in serum. (Pubitemid 351348154)
66. Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers. PLoS ONE 2008;3:e3148
67. Yu CH, Xu CF, Li YM. Association of microRNA-223 expression with hepatic ischemia/reperfusion injury in mice. Dig Dis Sci 2008 [doi: 10.1007/s10620-008- 0629-8]
68. Slaby O, Svoboda M, Fabian P, et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 2007;72:397-402 (Pubitemid 351238155)
69. Kamm RC, Smith AG. Nucleic acid concentrations in normal human plasma. Clin Chem 1972;18:519-522
70. Stroun M, Anker P, Maurice P, Gahan PB. Circulating nucleic acids in higher organisms. Int Rev Cytol 1977;51:1-48 (Pubitemid 8242413)
71. El-Hefnawy T, Raja S, Kelly L, et al. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem 2004;50:564-573 (Pubitemid 38297307)
72. Tsui NB, Ng EK, Lo YM. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem 2002;48:1647-1653
73. Sisco KL. Is RNA in serum bound to nucleoprotein complexes? Clin Chem 2001;47:1744-1745
74. Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9:654-659 (Pubitemid 47214727)
75. Ratajczak J, Miekus K, Kucia M, et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006;20:847-856
76. Smalheiser NR. Exosomal transfer of proteins and RNAs at synapses in the nervous system. Biol Direct 2007;2:35-49 (Pubitemid 351210952)
77. Yuan A, Farber EL, Rapoport AL, et al. Transfer of microRNAs by embryonic stem cell microvesicles. PLoS ONE 2009;4:e4722
78. Taylor DD, Homesley HD, Doellgast GJ. Binding of specific peroxidase-labeled antibody to placental-type phosphatase on tumor-derived membrane fragments. Cancer Res 1980;40:4064-4069 (Pubitemid 10030429)
79. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008;110:13-21 (Pubitemid 351853251)
80. Rabinowits G, Gercel-Taylor C, Day JM, et al. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 2009;10:42-46
81. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005;65:6029-6033 (Pubitemid 40994386)
82. Lotvall J, Valadi H. Cell to cell signalling via exosomes through esRNA. Cell Adh Migr 2007;1:156-158
83. Davoren PA, McNeill RE, Lowery AJ, et al. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol 2008;9:76-86
84. Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 2008;14:844-852 (Pubitemid 351574906)
85. Shell S, Park SM, Radjabi AR, et al. Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci USA 2007;104:11400-11405 (Pubitemid 47175152)
86. Corney DC, Flesken-Nikitin A, Godwin AK, et al. microRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 2007;67:8433-8438 (Pubitemid 47437414)
87. Jackson DB. Serum-based microRNAs: are we blinded by potential? Proc Natl Acad Sci USA 2008;106:E5
88. Sethupathy P, Megraw M, Hatzigeorgiou AG. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods 2006;3:881-886 (Pubitemid 44614721)
89. Krutzfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005;438:685-689
90. Esau C, Davis S, Murray SF, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006;3:87-98
91. Elmen J, Lindow M, Silahtaroglu A, et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 2008;36:1153-1162 (Pubitemid 351330933)
92. Bhat B, Esau C, Davis S, et al. 2′-O-methoxyethyl/2′-fluoro modified oligonucleotides result in more potent inhibition of microRNA-122 in vivo: a target implicated in HCV replication. Nucleic Acids Symp Ser (Oxf ) 2008;52-69
93. Mercatelli N, Coppola V, Bonci D, et al. The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. PLoS ONE 2008;3:e4029